Company / Cost of Revenue
HERBALIFE LTD. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.1B
FY2025
5-year range
$958.0M / $1.2B
FY2021-FY2025
Trend
+0.9%
vs FY2024
Sector context
#46 of 113
Health Care
What the data says
At $1.1B, HERBALIFE LTD.'s cost of revenue ranks #68 of 113 in the Health Care sector. Cost of Revenue has fluctuated over the past 10 years, ranging from $849M in FY2019 to $1.2B in FY2023.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +3.9%.
Improved from $1.2B to $1.1B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -1.7%
- 5-Year CAGR
- +3.9%
- 10-Year CAGR
- -
Sector benchmark
#68 of 113 in Health CareTop 59% of 113This company $1.1B Sector average $11.3B
▼
-90.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 0.9% year-over-year.
- Ranks #46 out of 113 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | +0.9% |
| FY2024 | $1.1B | -10.9% |
| FY2023 | $1.2B | +5.6% |
| FY2022 | $1.2B | +22.5% |
| FY2021 | $958.0M | +4.2% |
| FY2020 | $919.3M | +8.3% |
| FY2019 | $848.6M | -0.7% |
| FY2018 | $854.6M | -0.2% |
| FY2017 | $856.0M | -12.9% |
| FY2016 | $982.9M | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026